Literature DB >> 17085505

A computational study of the protein-ligand interactions in CDK2 inhibitors: using quantum mechanics/molecular mechanics interaction energy as a predictor of the biological activity.

Jans H Alzate-Morales1, Renato Contreras, Alejandro Soriano, Iñaki Tuñon, Estanislao Silla.   

Abstract

We report a combined quantum mechanics/molecular mechanics (QM/MM) study to determine the protein-ligand interaction energy between CDK2 (cyclin-dependent kinase 2) and five inhibitors with the N(2)-substituted 6-cyclohexyl-methoxy-purine scaffold. The computational results in this work show that the QM/MM interaction energy is strongly correlated to the biological activity and can be used as a predictor, at least within a family of substrates. A detailed analysis of the protein-ligand structures obtained from molecular dynamics simulations shows specific interactions within the active site that, in some cases, have not been reported before to our knowledge. The computed interaction energy gauges the strength of protein-ligand interactions. Finally, energy decomposition and multiple regression analyses were performed to check the contribution of the electrostatic and van der Waals energies to the total interaction energy and to show the capabilities of the computational model to identify new potent inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085505      PMCID: PMC1751410          DOI: 10.1529/biophysj.106.091512

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  40 in total

Review 1.  The conformational plasticity of protein kinases.

Authors:  Morgan Huse; John Kuriyan
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

2.  Preorganization and reorganization as related factors in enzyme catalysis: the chorismate mutase case.

Authors:  Sergio Martí; Juan Andrés; Vicent Moliner; Estanislao Silla; Iñaki Tuñón; Juan Bertrán
Journal:  Chemistry       Date:  2003-02-17       Impact factor: 5.236

Review 3.  Free energy simulations come of age: protein-ligand recognition.

Authors:  Thomas Simonson; Georgios Archontis; Martin Karplus
Journal:  Acc Chem Res       Date:  2002-06       Impact factor: 22.384

Review 4.  Designing specific protein kinase inhibitors: insights from computer simulations and comparative sequence/structure analysis.

Authors:  Christine Gould; Chung F Wong
Journal:  Pharmacol Ther       Date:  2002 Feb-Mar       Impact factor: 12.310

Review 5.  Progress toward the development of agents to modulate the cell cycle.

Authors:  Peter L Toogood
Journal:  Curr Opin Chem Biol       Date:  2002-08       Impact factor: 8.822

Review 6.  Protein flexibility and drug design: how to hit a moving target.

Authors:  Heather A Carlson
Journal:  Curr Opin Chem Biol       Date:  2002-08       Impact factor: 8.822

Review 7.  Pharmacological inhibitors of cyclin-dependent kinases.

Authors:  Marie Knockaert; Paul Greengard; Laurent Meijer
Journal:  Trends Pharmacol Sci       Date:  2002-09       Impact factor: 14.819

8.  Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.

Authors:  R Hoessel; S Leclerc; J A Endicott; M E Nobel; A Lawrie; P Tunnah; M Leost; E Damiens; D Marie; D Marko; E Niederberger; W Tang; G Eisenbrand; L Meijer
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

9.  Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor.

Authors:  Thomas G Davies; Johanne Bentley; Christine E Arris; F Thomas Boyle; Nicola J Curtin; Jane A Endicott; Ashleigh E Gibson; Bernard T Golding; Roger J Griffin; Ian R Hardcastle; Philip Jewsbury; Louise N Johnson; Veronique Mesguiche; David R Newell; Martin E M Noble; Julie A Tucker; Lan Wang; Hayley J Whitfield
Journal:  Nat Struct Biol       Date:  2002-10

10.  Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives.

Authors:  Ashleigh E Gibson; Christine E Arris; Johanne Bentley; F Thomas Boyle; Nicola J Curtin; Thomas G Davies; Jane A Endicott; Bernard T Golding; Sharon Grant; Roger J Griffin; Philip Jewsbury; Louise N Johnson; Veronique Mesguiche; David R Newell; Martin E M Noble; Julie A Tucker; Hayley J Whitfield
Journal:  J Med Chem       Date:  2002-08-01       Impact factor: 7.446

View more
  6 in total

1.  Correlation between biological activity and binding energy in systems of integrin with cyclic RGD-containing binders: a QM/MM molecular dynamics study.

Authors:  Mingli Xiang; Yuchun Lin; Gu He; Lijuan Chen; Mingli Yang; Shengyong Yang; Yirong Mo
Journal:  J Mol Model       Date:  2012-06-27       Impact factor: 1.810

2.  Docking and quantitative structure-activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors.

Authors:  Julio Caballero; Miguel Quiliano; Jans H Alzate-Morales; Mirko Zimic; Eric Deharo
Journal:  J Comput Aided Mol Des       Date:  2011-04-13       Impact factor: 3.686

3.  Bioactive focus in conformational ensembles: a pluralistic approach.

Authors:  Matthew Habgood
Journal:  J Comput Aided Mol Des       Date:  2017-11-30       Impact factor: 3.686

4.  Quantum mechanics study of the hydroxyethylamines-BACE-1 active site interaction energies.

Authors:  Carlos Gueto-Tettay; Juan Carlos Drosos; Ricardo Vivas-Reyes
Journal:  J Comput Aided Mol Des       Date:  2011-06-21       Impact factor: 3.686

5.  A quantum mechanic/molecular mechanic study of the wild-type and N155S mutant HIV-1 integrase complexed with diketo acid.

Authors:  Cláudio Nahum Alves; Sergio Martí; Raquel Castillo; Juan Andrés; Vicent Moliner; Iñaki Tuñón; Estanislao Silla
Journal:  Biophys J       Date:  2007-11-02       Impact factor: 4.033

6.  Intermolecular Interactions of Nucleoside Antibiotic Tunicamycin with On-Target MraYCB-TUN and Off-Target DPAGT1-TUN in the Active Sites Delineated by Quantum Mechanics/Molecular Mechanics Calculations.

Authors:  Elahe K Astani; Saeid Malek Zadeh; Ning-Shian Hsu; Kuan-Hung Lin; Soroush Sardari; Tsung-Lin Li
Journal:  ACS Omega       Date:  2022-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.